|Articles|May 16, 2011
Third agents for type 2 diabetes are similar in efficacy
NEW YORK (Reuters Health) - For patients with type 2 diabetes not controlled with metformin and a sulfonylurea, the choice of an additional agent should be based on individual clinical characteristics since improvements in glucose control are similar.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
2
How Pharmacies’ Ability to Provide Behavioral Health Services is Growing | NCPA 2025
3
Pharmacy Technology Should Focus on Patient Engagement, Peer Insight | NCPA 2025
4
American Pharmacists Month: Innovation Challenges Traditional Models, Favors Clinical Services
5